Pediatric Cancers

Latest News

The safety profile of iopofosine I 131 in the phase 1b CLOVER-2 trial appears consistent with prior reports of the agent.
Iopofosine I 131 Shows Preliminary Survival Benefit in Pediatric R/R Glioma

June 11th 2025

The safety profile of iopofosine I 131 in the phase 1b CLOVER-2 trial appears consistent with prior reports of the agent.

CHMP Recommends Mirdametinib for EU Approval in Adult/Pediatric NF1-PN
CHMP Recommends Mirdametinib for EU Approval in Adult/Pediatric NF1-PN

May 23rd 2025

FDA Grants RMAT Designation to CAR T Therapy for Incurable Pediatric Glioma
FDA Grants RMAT Designation to CAR T Therapy for Incurable Pediatric Glioma

May 16th 2025

Prophylactic defibrotide conferred more ICU admissions and higher mortality among high-risk pediatric patients who underwent prior HSCT.
Post-HSCT Defibrotide Does Not Reduce Sinusoidal Obstruction Syndrome

February 14th 2025

Data from the phase 3 MSB-GVHD001 trial support the FDA approval of remestemcel-L in pediatric SR-aGVHD.
FDA Approves Remestemcel-L in Pediatric SR-aGVHD

December 18th 2024

Latest CME Events & Activities

Medical Crossfire®: Precision Medicine in Glioma Treatment—Integration of Molecular Profiling to Inform Targeted Therapies

View More

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

View More

Epithelioid Sarcoma: Applying Clinical Updates to Real Patient Cases

View More

Collaborating Across the Continuum®: Identifying and Treating Epithelioid Sarcoma

View More

Mastering Epithelioid Sarcoma: Enhancing Diagnostic Precision and Tailoring Treatment Strategies

View More

Clinical Showcase™: Selecting the Best Next Steps for a Patient with Epithelioid Sarcoma

View More

<1
...
45678